“Clinically unmet needs” & the increased incidence of gastric cancer in the Asian population also caught my attention & reason for trials in Asia. Great interview. Thanks Qi Qi
IMU
Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
I haven't got time to watch it, but it just confirmed my view that Leslie was appointed MD to expand the commercial aspect of Imugene.
Someone mentioned about 4.5-5 years before manufacture? That reminded me of my conversation with her last week. I wanted to ask her about Phase 3 & how long before manufacture (I have my personal reason for this to be successful asap), but she cut me off before I finished my question, saying she wouldn't worry about Phase 3 because her focus is completing Ph2 successfully, and that between Ph1b & end of Ph2 big pharmas might come knocking. She then said without big pharma, a typical Ph3 trial might be over 10 years long, but big pharmas can expedite this to 4-5 years. If she mentioned in the interview about 4.5-5 years, does that mean she's confident of a deal reached by then?
IMU
Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
